Total Payments
$6,356
2024 Payments
$135.76
Companies
35
Transactions
342
Medicare Patients
17,156
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$5,831 (91.7%)
Education$524.77 (8.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,831 | 330 | 91.7% |
| Education | $524.77 | 12 | 8.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,509 | 69 | $0 (2023) |
| AbbVie Inc. | $527.19 | 64 | $0 (2020) |
| NeoTract Inc. | $448.76 | 13 | $0 (2020) |
| Janssen Biotech, Inc. | $434.95 | 20 | $0 (2020) |
| PFIZER INC. | $371.11 | 21 | $0 (2020) |
| TOLMAR Pharmaceuticals, Inc. | $315.52 | 17 | $0 (2020) |
| Ferring Pharmaceuticals Inc. | $314.81 | 12 | $0 (2024) |
| Amgen Inc. | $256.14 | 13 | $0 (2020) |
| Allergan, Inc. | $178.67 | 12 | $0 (2020) |
| Antares Pharma, Inc. | $159.50 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $135.76 | 1 | Ferring Pharmaceuticals Inc. ($135.76) |
| 2023 | $42.83 | 1 | Astellas Pharma US Inc ($42.83) |
| 2022 | $144.92 | 2 | Boston Scientific Corporation ($98.12) |
| 2021 | $149.03 | 2 | Teleflex LLC ($149.03) |
| 2020 | $1,006 | 42 | Astellas Pharma US Inc ($327.98) |
| 2019 | $1,723 | 108 | Astellas Pharma US Inc ($345.70) |
| 2018 | $1,644 | 102 | Astellas Pharma US Inc ($412.19) |
| 2017 | $1,510 | 84 | Astellas Pharma US Inc ($380.33) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $135.76 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $42.83 | General |
| Category: Oncology | ||||||
| 11/03/2022 | Boston Scientific Corporation | LITHOCLAST (Device) | Food and Beverage | In-kind items and services | $98.12 | General |
| Category: EMS Swiss LithoClast Triology_URO | ||||||
| 03/16/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Education | In-kind items and services | $46.80 | General |
| Category: Urology | ||||||
| 12/10/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $141.06 | General |
| Category: Interventional Urology | ||||||
| 06/10/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Interventional Urology | ||||||
| 11/09/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $65.00 | General |
| 11/05/2020 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | Cash or cash equivalent | $29.01 | General |
| Category: CONTINENCE AND CRITICAL CARE | ||||||
| 10/29/2020 | Rochester Medical Corporation | — | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Medical Systems | ||||||
| 10/23/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $38.03 | General |
| Category: Kidney Stones | ||||||
| 10/01/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2020 | Antares Pharma, Inc. | OTREXUP (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Rheumatoid Arthritis | ||||||
| 09/18/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/10/2020 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Oncology | ||||||
| 09/04/2020 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 08/25/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: ONCOLOGY | ||||||
| 08/24/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $98.95 | General |
| 08/18/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/10/2020 | Myriad Genetic Laboratories, Inc. | BRACANALYSIS CDX (Device) | Food and Beverage | Cash or cash equivalent | $12.30 | General |
| Category: GERMLINE DNA SEQUENCING HEREDITARY CANCER AND REARRANGEMENT ANALYSIS | ||||||
| 08/06/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Kidney Stones | ||||||
| 07/23/2020 | Antares Pharma, Inc. | OTREXUP (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Rheumatoid Arthritis | ||||||
| 07/20/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,413 | 11,719 | $2.1M | $341,330 |
| 2022 | 27 | 4,211 | 13,618 | $2.4M | $401,260 |
| 2021 | 34 | 4,432 | 9,963 | $2.5M | $456,997 |
| 2020 | 43 | 5,100 | 12,050 | $2.7M | $490,618 |
Total Patients
17,156
Total Services
47,350
Medicare Billing
$1.7M
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 918 | 1,130 | $436,346 | $70,226 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 582 | 735 | $399,855 | $69,950 | 17.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 157 | 219 | $240,665 | $39,910 | 16.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 32 | 286 | $181,426 | $39,033 | 21.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 23 | 4,700 | $90,700 | $23,348 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 121 | 121 | $93,896 | $14,622 | 15.6% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 267 | 310 | $116,184 | $13,506 | 11.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 111 | 125 | $68,092 | $11,629 | 17.1% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 24 | 33 | $56,949 | $10,470 | 18.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 94 | 94 | $47,843 | $7,112 | 14.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 35 | 35 | $40,889 | $6,229 | 15.2% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 143 | 169 | $68,879 | $6,046 | 8.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 45 | 45 | $41,414 | $5,038 | 12.2% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 12 | 2,200 | $19,800 | $4,637 | 23.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 25 | $19,081 | $3,595 | 18.8% |
| 51705 | Simple change of bladder tube | Office | 2023 | 14 | 44 | $18,866 | $3,384 | 17.9% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 33 | 69 | $23,805 | $3,050 | 12.8% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 15 | 45 | $26,505 | $2,962 | 11.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 181 | 222 | $35,792 | $1,815 | 5.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 474 | 735 | $13,230 | $1,617 | 12.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 32 | 49 | $8,134 | $1,204 | 14.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 107 | $11,556 | $1,055 | 9.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 21 | $5,087 | $740.00 | 14.5% |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | Office | 2023 | 11 | 48 | $536.00 | $88.05 | 16.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 34 | 152 | $608.00 | $61.95 | 10.2% |
About Dr. Thomas Kingston, MD
Dr. Thomas Kingston, MD is a Urology healthcare provider based in Salem, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790744597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Kingston, MD has received a total of $6,356 in payments from pharmaceutical and medical device companies, with $135.76 received in 2024. These payments were reported across 342 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,831).
As a Medicare-enrolled provider, Kingston has provided services to 17,156 Medicare beneficiaries, totaling 47,350 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Salem, MA
- Active Since 03/21/2006
- Last Updated 06/17/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1790744597
Products in Payments
- XTANDI (Drug) $1,135
- Erleada (Drug) $364.45
- Urolift - UL400 (Device) $331.10
- ELIGARD (Drug) $315.52
- Prolia (Biological) $256.14
- Myrbetriq (Drug) $252.27
- Lupron (Drug) $173.90
- Xtandi (Drug) $170.89
- Noctiva (Drug) $152.36
- UroLift System (Device) $149.03
- FIRMAGON (Drug) $146.52
- Lupron Depot (Drug) $142.60
- (815) Thiola (Drug) $136.63
- ADSTILADRIN (Biological) $135.76
- Androgel (Drug) $134.02
- Natesto (Drug) $129.90
- BOTOX (Biological) $128.70
- Axumin (Drug) $124.83
- UroLift (Device) $117.66
- XIAFLEX (Biological) $111.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salem
Dr. Mark Laspina, D.o, D.O
Urology — Payments: $19,777
Urology $19,777
Stuart Diamond, Md, MD
Urology — Payments: $18,471
Urology $18,471
Dr. Alejandra Balen, M.d, M.D
Urology — Payments: $14,486
Urology $14,486
Bradley Warner, M.d, M.D
Urology — Payments: $10,038
Urology $10,038
Mr. Noel Defelippo, Md, MD
Urology — Payments: $8,224
Urology $8,224
Dr. John Mhoon, M.d, M.D
Urology — Payments: $7,907
Urology $7,907